National Investment Services’s Lifecore Biomedical LFCR Stock Holding History

National Investment Services’s Portfolio LFCR Stock Details LFCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-28,314	Closed	-$308K	–	33
2019 Q3	$308K	Sell	28,314 -106	-0.4%	-$1.15K	0.36%	70
2019 Q2	$266K	Hold	28,420	–	–	0.31%	71
2019 Q1	$349K	Hold	28,420	–	–	0.38%	70
2018 Q4	$336K	Sell	28,420 -8,130	-22%	-$112K	0.39%	70
2018 Q3	$526K	Buy	36,550 +480	+1%	+$6.64K	0.52%	65
2018 Q2	$537K	Buy	36,070 +21,581	+149%	+$300K	0.5%	62
2018 Q1	$189K	Buy	+14,489	New	+$190K	0.18%	76

Other funds holding LFCR

Wynnefield Capital New York $145M AUM 14.57% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

NIMC

NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Walthausen & Co Malta, New York $120M AUM 2.66% 1-Year Est. Return

LPAM

Legion Partners Asset Management Los Angeles, California $138M AUM 53.69% 1-Year Est. Return

Heartland Advisors Milwaukee, Wisconsin $2.25B AUM 44.61% 1-Year Est. Return

ICOM

Investment Counselors of Maryland Baltimore, Maryland $4.37B AUM 76.25% 1-Year Est. Return

National Investment Services's LFCR Position: Q4 2019 in Review

National Investment Services sold out of Lifecore Biomedical (LFCR) in Q4 2019, closing a stake of 28,314 shares — an estimated $308K sold.

National Investment Services first reported a position in LFCR in Q1 2018 and held it in 7 quarters. The position peaked at $537K in Q2 2018. 93 funds tracked by Wall St. Rank hold LFCR as of Q4 2019.

National Investment Services reported no remaining Lifecore Biomedical position as of Q4 2019 after selling out during the quarter.
National Investment Services sold 28,314 Lifecore Biomedical shares in Q4 2019, an estimated $308K.
National Investment Services first reported a position in Lifecore Biomedical in Q1 2018 and held it in 7 quarters.
National Investment Services's Lifecore Biomedical position peaked at $537K in Q2 2018.
93 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q4 2019.

Based on National Investment Services's 13F filing for Q4 2019.